GB/T 29889-2013
ActiveDNA microarray for disease susceptibility DNA polymorphisms
人体疾病易感DNA多态性检测基因芯片
Application Summary AI generated
This standard specifies the technical requirements, test methods, and quality control for DNA microarrays used to detect human disease susceptibility polymorphisms. It is applied in clinical genetic testing and healthcare settings to identify genetic variants associated with increased risk for common diseases, such as diabetes or hypertension. The standard ensures the reliability and consistency of microarray-based diagnostic products used by medical laboratories and biotechnology manufacturers.
Related Standards
GB/T 19381-2003
General methods of test for medical closures of butyl rubber
GB/T 14214-2003
Spectacle frames--General requirements and test methods
GB/T 18375.6-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 6:Loading parameters of supplementary structural tests
GB/T 18375.7-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 7:Test submission document
GB/T 18375.5-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 5:Supplementary structural tests
GB/T 19543-2004
Prostheses--Structural testing of hip units
GB/T 18375.8-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 8:Test report
GB/T 19629-2005
Medical Electrical Equipment-Dosimeters with ionization chambers and/or semi-conductors as used in X-ray diagnostic imaging
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.